Apoptosis pp 130-149 | Cite as

Clusterin: A Role in Cell Survival in the Face of Apoptosis?

  • C. Koch-Brandt
  • C. Morgans
Part of the Progress in Molecular and Subcellular Biology book series (PMSB, volume 16)

Abstract

Clusterin is a multifunctional glycoprotein complex found in virtually all body fluids and on the surface of cells lining body cavities. Demonstrated and proposed functions include the transport of lipoproteins, the inhibition of complementmediated cell lysis and the modulation of cell-cell interactions. On the basis of its elevated expression in apoptotic tissues, it was originally proposed that the protein might be casually involved in apoptosis. Here, we discuss the recent data that, in contrast to the earlier notion, suggest that clusterin expression is not enhanced, but rather is down-regulated in the cells undergoing apoptosis and that its expression in the apoptotic tissue is restricted to the vital neighboring cells. These results led to the proposal that rather than being a cell death gene, clusterin is a cell survival gene, exerting a protective function on the surving bystander cells.

Keywords

Estrogen Heparin Adenosine Oncol Luminal 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Appeal D, Koch-Brandt C (1994) Sorting of a secretory protein (gp80) to the apical surface of Caco-2 cells. J Cell Sci 107: 553–559Google Scholar
  2. Bettuzzi S, Hiipakka RA, Gilna P, Liao S (1989) Identification of an androgen-repressed mRNA in rat ventral prostate as coding for sulfated glycoprotein 2 by cDNA cloning and sequence analysis. Biochem J 257: 293–299PubMedGoogle Scholar
  3. Bettuzzi S, Troiano L, Davalli P, Tropea F, Ingletti MC, Grassilli E, Monti D, Cori A, Franceschi C (1991) In vivo accumulation of sulfated glycoprotein 2 mRNA in rat thymocytes upon dexamethasone-induced cell death. Biochem Biophys Res Commun 175: 810–815PubMedCrossRefGoogle Scholar
  4. Bissonnette RP, Shi Y, Mahboubi A, Glynn JM, Green DR (1994) c-myc and apoptosis. In: Tomei LD, Cope FO (eds) Apoptosis II: the molecular basis of apoptosis in disease. Cold Spring Harbor Lab Press, New York, pp 327–356Google Scholar
  5. Blaschuk O, Burdzy K, Fritz IB (1993) Purification and characterization of a cell-aggregating factor (clusterin), the major glycoprotein in ram rete testis fluid. J Biol Chem 258: 7714–7720Google Scholar
  6. Brandyk M, Buttyan R, Olsson CA, Appeal G, D’Agati V, Katz A, Ng PY, Sawczuk IS (1990) TRPM-2 detection and localization during gentamicin-induced nephrotoxicity. J Urol 143: 239AGoogle Scholar
  7. Bredesen DE (1994) Neuronal apoptosis: genetic and biochemical modulation. In: Tomei LD, Cope FO (eds) Apoptosis II: the molecular basis of apoptosis in disease. Cold Spring Harbor Lab Press, New York, pp 397–421Google Scholar
  8. Brown DG, Sun XM, Cohen GM (1993) Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to intemucleosomal fragmentation. J Biol Chem 268: 3027–3039Google Scholar
  9. Bursch W, Lauer B, Timmermann-Trosiener I, Barthel G, Schuppler J, Schulte-Hermann R (1984) Controlled cell death (apoptosis) of nonmal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis 5: 453–458PubMedCrossRefGoogle Scholar
  10. Bursch W, Oberhammer F, Schulte-Hermann R (1992a) Cell death by apoptosis and its protective role against disease. Trends Pharmacol Sci 13: 245–251PubMedCrossRefGoogle Scholar
  11. Bursch W, Fesus L, Schulte-Hermann R (1992b) Apoptosis (‘programmed’ cell death) and its relevance in liver injury and carcinogenesis. In: Dekant W, Neumann HG (eds) Tissue-specific toxicity: biochemical mechanisms. Academic Press, London, pp 95–115Google Scholar
  12. Bursch W, Gleeson T, Kleine L, Tenniswood M (1995) Expression of clusterin/testosterone-repressed prostate message (TRPM-2) mRNA during growth and regression of rat liver. Arch Toxicol 69: 253–258PubMedCrossRefGoogle Scholar
  13. Buttyan R (1991) Genetic reponse of prostate cells to androgen deprivation: insights into the cellular mechanism of apoptosis. In: Tomei LD, Cope FO (eds) Apoptosis: the molecular basis of cell death. Cold Spring Harbor Lab Press, New York, pp 157–173Google Scholar
  14. Buttyan R, Olsson CA, Pintar J, Chang C, Bandyk M, Ng PY, Sawczuk IS (1989) Induction of the TRPM-2 gene in cells undergoing programmed cell death. Mol Cell Biol 9: 3473–3481PubMedGoogle Scholar
  15. Cheng YC, Mathur PP, Grima J (1988) Structural analysis of clusterin and its subunits in ram rete testis fluid. Biochemistry 27: 4079–4088PubMedCrossRefGoogle Scholar
  16. Choi-Miura NH, Takahashi Y, Nakano Y, Tobe T, Tomito M (1992) Identification of the disulfide bonds in human plasma protein SP-40, 40 (Apolipoprotein-J). J Biochem 112: 557–561PubMedGoogle Scholar
  17. Collard MW, Griswold MD (1987) Biosynthesis and molecular cloning of sulfated glycoprotein 2 secreted by rat sertoli cells. Biochemistry 26: 3297–3303PubMedCrossRefGoogle Scholar
  18. Collins MKL, Rivas AL (1993) The control of apoptosis in mammalian cells. Trends Biochem 18: 307–309CrossRefGoogle Scholar
  19. Danik M, Chabot J-G, Mercier C, Benabid A, Chauvin C, Quirion R, Suh M (1991) Human gliomas and epileptic foci express high levels of a mRNA related to rat testicular sulfated glycoprotein 2, a purported marker of cell death. Proc Natl Acad Sci USA 88: 8577–8581PubMedCrossRefGoogle Scholar
  20. Danik M, Chabot J-G, Hassan-Gonzales D, Suh M, Quirion R (1993) Localization of sulfated glycoprotein-2/clusterin mRNA in the rat brain by in situ hybridization. J Comp Neurol 331: 209–227CrossRefGoogle Scholar
  21. Davidson NE, Lippman ME (1988) Treatment of metastatic breast cancer. In: Lippman ME, Lichter AS, Danforth DN (eds) Diagnosis and management of breast cancer. WB Saunders, London, pp 375–406Google Scholar
  22. Dent AL, Matis LA, Hooshmand, F, Widacki SM, Bluestone JA, Herdick SM (1990) Self-reactive gamma delta T cells are eliminated in the thymus. Nature 343: 714–719PubMedCrossRefGoogle Scholar
  23. De Silva HV, Harmony JAK, Stuart WD, Gil CM, Robbins J (1990) Apolipoprotein J: structure and tissue distribution. Biochemistry 29: 5380–5389PubMedCrossRefGoogle Scholar
  24. Diemer V, Hoyle M, Baglioni C, Millis AJT (1992) Expression of porcine complement cytolysis inhibitor mRNA in cultured aortic smooth muscle cells. J Biol Chem 267: 5257–5264PubMedGoogle Scholar
  25. Duguid JR, Bohmont CW, Liu N, Tourtellotte WW (1989) Changes in brain gene expression shared by scrapie and Alzheimer disease. Proc Natl Acad Sci USA 86: 7260–7264PubMedCrossRefGoogle Scholar
  26. Ellis RE, Yuan J, Horvitz HR (1991) Mechanisms and functions of cell death. Annu Rev Cell Biol 7: 663–698PubMedCrossRefGoogle Scholar
  27. English HF, Kyprianou N, Isaacs JT (1989) Relationship between DNA fragmentation and apoptosis in the programmed cell death in the rat prostate following castration. Prostate 7:41–49CrossRefGoogle Scholar
  28. Filipski J, Leblanc, J, Youdale T, Sikorska M, Walker PR (1990) Periodicity of DNA folding in higher order chromatin structures. EMBO J 9: 1319–1327PubMedGoogle Scholar
  29. French LE, Chonn A, Ducrest D, Baumann B, Belin D, Wohlwend A, Kiss JZ, Sappino A-P, Tschopp J, Schifferli JA (1993) Molecular cloning and mRNA localization of a gene associated with epithelial differentiation processes during embryogenesis. J Cell Biol 122: 1119–1130PubMedCrossRefGoogle Scholar
  30. French LE, Sappino A-P, Tschopp J, Schifferli JA (1992) Distinct sites of production of the putative cell death marker clusterin in the human thymus. J Clin Invest 90: 1919–1925PubMedCrossRefGoogle Scholar
  31. French LE, Sappino, A-P, Tschopp J, Schifferli JA (1994a) Clusterin gene expression in the rat thymus is not modulated by dexamethasone treatment. Immunology 82: 328–331PubMedGoogle Scholar
  32. French LE, Wohlwend A, Sappino A-P, Tschopp J, Schifferli JA (1994b) Human clusterin gene expression is confined to surviving cells during in vitro programmed cell death. J Clin Invest 93: 877–884PubMedCrossRefGoogle Scholar
  33. Fritz IB, Burdzy K (1989) Novel action of carnitine: inhibition of aggregation of dispersed cells elicited by clusterin in vitro. J Cell Physiol 140: 18–28PubMedCrossRefGoogle Scholar
  34. Fritz IB, Burdzy K, Setchell B, Blaschuk O (1983) Ram rete testis fluid contains a protein (clusterin) which influences cell-cell interactions in vitro. Biol Reprod 28: 1173–1188PubMedCrossRefGoogle Scholar
  35. Furuya Y, Berges R, Lundmo P, Isaacs JT (1994) Cell proliferation, p53 gene expression, and intracellular calcium in programmed cell death: prostate model. In: Tomei LD, Cope FO (eds) Apoptosis II: the molecular basis of apoptosis in disease. Cold Spring Harbor Lab Press, New York, pp 231–252Google Scholar
  36. Garden GA, Bothwell M, Rubel EW (1991) Lack of correspondence between mRNA expression for a putative cell death molecule (SGP-2) and neuronal cell death in the central nervous system. J Neurobiol 22: 590–604PubMedCrossRefGoogle Scholar
  37. Gougeon ML, Montagnier L (1994) Apoptosis in peripheral lymphocytes during HIV infection: influence of superantigens and correlation with AIDS pathogenesis. In: Tomei LD, Cope FO (eds) Apoptosis II: the molecular basis of apoptosis in disease. Cold Spring Harbor Lab Press, New York, pp 5–20Google Scholar
  38. Griswold MD, Roberts K, Bishop P (1986) Purification and characterization of sulfated glycoprotein secreted by Sertoli cells. Biochemistry 25: 7265–7270PubMedCrossRefGoogle Scholar
  39. Hartmann K, Rauch J, Urban J, Parcyk K, Diel P, Pilarsky C, Appel D, Haase W, Mann K, Weller A, Koch-Brandt C (1991) Molecular cloning of gp80, a glycoprotein complex secreted by kidney cells in vivo. J Biol Chem 266: 9924–9931PubMedGoogle Scholar
  40. Helminen HJ, Ericson JLE (1972) Ultrastructural studies on prostatic involution in the rat. Evidence for focal irreversible damage to epithelium and heterophagic digestion in macrophages. J Ultrastruct Res 39: 443–452PubMedCrossRefGoogle Scholar
  41. Hovanessian AG (1994) Apoptosis in HIV-infection: the rule of extracellular and transmembrane glycoproteins. In: Tomei LD, Cope FO (eds) Apoptosis II: the molecular basis of apoptosis in disease. Cold Spring Harbor Lab Press, New York, pp 21–42Google Scholar
  42. Humphries P, Kenna P, Farrar GJ (1992) On the molecular genetics of retinitis pigmentosa. Science 256: 804–813PubMedCrossRefGoogle Scholar
  43. Huttner WB, Gerdes H-H, Rosa P (1991) The granin (chromogranin/secretogranin) family. Trends Biochem Sci 16: 27–30PubMedCrossRefGoogle Scholar
  44. Jenne DE, Tschopp J (1989) Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: identity to sulfated glycoprotein 2, a constituent of rat testis fluid. Proc Natl Acad Sci USA 86: 7123–7127PubMedCrossRefGoogle Scholar
  45. Jenne DE, Tschopp J (1992) Clusterin: the intriguing guises of a widely expressed glycoprotein. Trends Biochem Sci 17: 154–159PubMedCrossRefGoogle Scholar
  46. Jenne DE, Lowin B, Peitsch MC, Böttcher A, Schitz G, Tschopp J (1991) Clusterin (complement lysis inhibitor) forms a high density lipoprotein complex with apolipoprotein A-1 in human plasma. J Biol Chem 266: 11030–11036PubMedGoogle Scholar
  47. Jomary C, Murphy BF, Neal MJ, Jones SE (1993a) Abnormal distribution of retinal clusterin in retinitis pigmentosa. Mol Brain Res 20: 274–278PubMedCrossRefGoogle Scholar
  48. Jomary C, Neal MJ, Jones SE (1993b) Comparison of clusterin gene expression in normal and dystrophic human retinas. Mol Brain Res 20: 279–284PubMedCrossRefGoogle Scholar
  49. Jones SE, Wood-Gush HG, Cunningham JR, Szczesny PJ, Neal MJ (1990) Abnormalities in expression of human retinal mRNA in retinitis pigmentosa. Neurochem Int 17: 495–503PubMedCrossRefGoogle Scholar
  50. Jones SE, Meerabux JMA, Yeats DA, Neal MJ (1992) Analysis of differentially expressed genes in retinitis pigmentosa retinas: altered expression of clusterin mRNA. FEBS Lett 300: 279–282PubMedCrossRefGoogle Scholar
  51. Jordan-Starck TC, Witte DP, Aronow BJ, Harmony JAK (1992) Apolipoprotein J: a membrane policeman. Curr Opin Lipidol 3: 75–85CrossRefGoogle Scholar
  52. Kadomatsu K, Anzano MA, Slayter V, Winokur TS, Smith JM, Sporn MB (1993) Expression of sulfated glycoprotein 2 is associated with carcinogenesis induced by N-nitroso-N-methylurea in rat prostate and seminal vesicle. Cancer Res 53: 1480–1483PubMedGoogle Scholar
  53. Kerr JFR, Harmon BV (1991) Definition and incidence of apoptosis: an historical perspective. In: Tomei LD, Cope FO (eds) Apoptosis: the molecular basis of cell death. Cold Spring Harbor Lab Press, New York, pp 5–30Google Scholar
  54. Kirszbaum L, Sharpe JA, Murphy B, d’Apice JF, Classon B, Hudson P, Walker ID (1989) Molecular cloning and characterization of the noval, human complement-associated protein, SP 40, 40: a link between the complement and reproductive systems. EMBO J 8: 711–718PubMedGoogle Scholar
  55. Kirszbaum L, Bozas WE, Walker ID (1992) SP-40, 40, a protein involved in the control of the complement pathway, possesses a unique array of disulphide bridges. FEBS Lett 297: 70–76PubMedCrossRefGoogle Scholar
  56. Kounnas MZ, Loukinova EB, Stefansson S, Harmony JAK, Brewer BH, Strickland DK, Argraves WS (1995) Identification of glycoprotein 330 as an endocytic receptor for Apolipoprotein J/ Clusterin. J Biol Chem 270: 13070–13075PubMedCrossRefGoogle Scholar
  57. Kure S, Tominaga T, Yoshimoto T, Tada K, Narisawa K (1991) Glutamate triggers internucleosomal DNA cleavage in neuronal cells. Biochem Biophys Res Commun 179: 39–46PubMedCrossRefGoogle Scholar
  58. Kyprianou N, English HF, Isaacs JT (1988) Activation of a Ca++-Mg++-dependent endonuclease as an early event in castration-induced prostate cell death. Prostate 13: 103–109PubMedCrossRefGoogle Scholar
  59. Kyprianou N, English HF, Isaacs JT (1990) Programmed cell death during the regression of PC-82 human prostate cancer following androgen ablation. Cancer Res 50: 3748–3753PubMedGoogle Scholar
  60. Kyprianou N, English HF, Davidson NE, Isaacs JT (1991) Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res 51: 162–166PubMedGoogle Scholar
  61. Laping NJ, Morgan TE, Nichols NR, Rozovsky I, Young-Chan Cs, Zarow C, Finch CE (1994) Transforming growth factor-β1 induces neuronal and astrocyte genes: tubulin α1, glial fibrillary acidic protein and clusterin. Neuroscience 58: 563–572PubMedCrossRefGoogle Scholar
  62. Laslop A, Steiner H-J, Egger C, Wolkersdorfer M, Kapelari S, Hogue-Angeletti R, Erickson JD, Fischer-Colbrie R, Winkler H (1993) Glycoprotein III (clusterin, sulfated glycoprotein 2) in endocrine, nervous, and other tissues: immunochemical characterization, subcellular localization, and regulation of bisynthesis. J Neurochem 61: 1498–1505PubMedCrossRefGoogle Scholar
  63. Lee S, Christakos S, Small MB (1993) Apoptosis and signal transduction: clues to a molecular mechanism. Curr Op in Cell Biol 5: 286–291CrossRefGoogle Scholar
  64. MacDonald HR, Lees RK (1990) Programmed death of autoreactive thymocytes. Nature 343: 642–644PubMedCrossRefGoogle Scholar
  65. Martin SJ (1993) Apoptosis: suicide, execution or murder. Trends Cell Biol 3: 141–144PubMedCrossRefGoogle Scholar
  66. May PC, Finch CE (1992) Sulfated glycoprotein 2: new relationships of this multifunctional protein to neurodegeneration. Trends Neurosci 15: 391–396PubMedCrossRefGoogle Scholar
  67. May PC, Lampert-Etchells M, Johnson SA, Poirier J, Masters JN, Finch CE (1990) Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer’s disease and in response to experimental lesions in rat. Neuron 5: 831–839PubMedCrossRefGoogle Scholar
  68. May PC, Robinson P, Fuson K, Smalstig B, Stephenson D, Clemens JA (1992) Sulfated glycoprotein- 2 expression increases in rodent brain after transient global ischemia. Mol Brain Res 15: 33–39PubMedCrossRefGoogle Scholar
  69. Michel D, Gillet G, Volovitch M, Pessac B, Calothy G, Brun G (1989) Expression of a noval gene encoding a 51.5 kD precursor protein is induced by different retroviral oncogenes in quail neuroretinal cells. Oncogene Res 4: 127–136PubMedGoogle Scholar
  70. Montpetit ML, Lawless KR, Tenniswood M (1986) Androgen-repressed messages in the rat ventral prostate. Prostate 8: 25–36PubMedCrossRefGoogle Scholar
  71. Murphy BF, Kirszbaum L, Walker ID, d’Apice AJF (1988) SP-40, 40 a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis. J Clin Invest 81: 1858–1864PubMedCrossRefGoogle Scholar
  72. Nagata S (1994) Apoptosis-mediating Fas antigen and its natural mutation. In: Tomei LD, Cope FO (eds) Apoptosis II: the molecular basis of apoptosis in disease. Cold Spring Harbor Lab Press, New York, pp 313–326Google Scholar
  73. Oberhammer F, Wilson JW, Dive C, Morris ID, Hickman JA, Wakeling AE, Walker PR, Sikorska M (1993) Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 12: 3679–3684PubMedGoogle Scholar
  74. O’Bryan MK, Cheema SS, Barlett PF, Murphy BF, Pearse MJ (1993) Clusterin levels increase during neuronal development. J Neurobiol 25: 421–432CrossRefGoogle Scholar
  75. Osborne BA, Schwartz LM (1994) Essential genes that regulate apoptosis. Trends Cell Biol 4: 394–399PubMedCrossRefGoogle Scholar
  76. Palmar DJ, Christie DL (1990) The primary structure of glycoprotein III from bovine adrenal meduallary chromaffin granules. J Biol Chem 265: 6617–6623Google Scholar
  77. Parczyk K, Pilarsky C, Rachel U, Koch-Brandt C (1994) Gp80 (clusterin; TRPM-2) mRNA level is enhanced in human renal clear cell carcinomas. J Cancer Res Clin Oncol 120: 186–188PubMedCrossRefGoogle Scholar
  78. Pasinetti GM, Johnson SA, Oda T, Rozovsky I, Finch CE (1994) Clusterin (SGP-2): a multifunctional glycoprotein with regional expression in astrocytes and neurons of the adult rat brain. J Comp Neurol 339: 387–400PubMedCrossRefGoogle Scholar
  79. Peitsch MC, Mannherz HG, Tschopp J (1994) The apoptosis endonucleases: cleaning up after cell death? Trends Cell Biol 4: 37–41PubMedCrossRefGoogle Scholar
  80. Pignataro OP, Feng Z-M, Chen C (1992) Cyclic adenosine 3′, 5′ -monophosphate negatively regulates clusterin gene expression in Leydig tumor cell lines. Endocrinology 130: 2745–2750PubMedCrossRefGoogle Scholar
  81. Pilarsky C, Haase W, Koch-Brandt C (1993) Stable expression of gp80 (TRPM-2, clusterin), a secretory protein implicated in programmed cell death, in transfected BHK-21 cells. Biochim Biophys Acta 1179: 306–310PubMedCrossRefGoogle Scholar
  82. Purello M, Betuzzi S, DiPietro C, Mirabile E, Di Blasi M, Rimini R, Grzeschik KH, Ingletti C, Corti A, Sichel G (1991) The gene for SP-40,40, human homolog of rat sulfated glycoprotein 2 rat clusterin, and rat testosterone-repressed prostatic message 2, maps to chromosome 8. Genomics 10: 151–156CrossRefGoogle Scholar
  83. Raff MC (1992) Social controls on cell survival and cell death. Nature 356: 397–400PubMedCrossRefGoogle Scholar
  84. Rennie PS, Bruchovsky N, Buttyan R, Benson M, Cheng H (1988) Gene expression during the early phases of regression of the androgen-dependent Shionogi mouse mammary carcinoma. Cancer Res 48: 6309–6312PubMedGoogle Scholar
  85. Sawczuk IS, Hoke Olsson CA, Connor J, Buttyan R (1989) Gene expression in response to acute unilateral ureteral obstruction. Kidney Int 35: 1315–1321PubMedCrossRefGoogle Scholar
  86. Sensibar JA, Griswold MD, Sylvester SR, Buttyan R, Bardin CW, Cheng CY, Dudek S, Lee C (1991) Prostatic ductal system in rats: regional variation in localization of an androgen-repressed gene product, sulfated glycoprotein-2. Endocrinology 128: 2091–2102PubMedCrossRefGoogle Scholar
  87. Sloviter RS, Sollas AL, Dean E, Neubart S (1993) Adrenalectomy-induced granule cell degeneration in the rat hippocampal dentate gyrus: characterization of an in vivo model of controlled neuronal death. J Comp Neurol 330: 324–336PubMedCrossRefGoogle Scholar
  88. Smith CA, Williams GT, Kingston R, Jenkinson EJ, Owen JJT (1989) Antibodies to CD3/T cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337: 181–184PubMedCrossRefGoogle Scholar
  89. Smith CA, Grimes EA, McCarthy NJ, Williams GT (1994) Multiple gene regulation of apoptosis: Significance in immunology and oncology. In: Tomei LD, Cope FO (eds) Apoptosis II: the molecular basis of apoptosis in disease. Cold Spring Harbor Press, New York, pp 43–88Google Scholar
  90. Tenniswood M, Taillefer D, Lakins J, Guenette R, Mooibroek M, Daehlin L, Welsh J (1994) Control of gene expression during apoptosis in hormone-dependent tissues. In: Tomei LD, Cope FO (eds) Apoptosis II: the molecular basis of apoptosis in disease. Cold Spring Harbor Lab Press, New York, pp 283–311Google Scholar
  91. Tschopp J, Jenne DE, Hertig S, Preissner KT, Morgenstern H, Sapino A-P, French L (1993) Human megakaryocytes express clusterin and package it without apolipoprotein A-1 into α-granules. Blood 82: 118–125PubMedGoogle Scholar
  92. Urban J, Parczyk K, Leutz A, Kayne M, Kondor-Koch C (1987) Constitutive apical secretion of an 80-kD sulfated glycoprotein complex in the polarized epithelial Madin-Darby canine kidney cell line. J Cell Biol 105: 2735–2743PubMedCrossRefGoogle Scholar
  93. Van der Wal EA, Gomez-Pinilla F, Cotman CW (1993) Transforming growth factor-β1 is in plaques in Alzheimer and Down pathologies. Neuro Rep 4: 69–72Google Scholar
  94. Wadewitz AG, Lockshin RA (1988) Programmed cell death: dying cells synthesize a co-ordinated, unique set of proteins in two different episodes of cell death. FEBS Lett 241: 19–23PubMedCrossRefGoogle Scholar
  95. White E, Gooding LR (1994) Regulation of apoptosis by human adenoviruses. In: Tomei LD, Cope FO (eds) Apoptosis II: the molecular basis of apoptosis in disease. Cold Spring Harbor Lab Press, New York, pp 111–142Google Scholar
  96. White K, Grether ME, Abrams JM, Young L, Farrell K, Steller H (1994) Genetic control of programmed cell death in Drosophila. Science 264: 677–683PubMedCrossRefGoogle Scholar
  97. Wiessner C, Back T, Bonnekoh P, Kohno K, Gehrmann J, Hossmann KA (1993) Sulfated glycoprotein-2 mRNA in the rat brain following transient forebrain ischemia. Mol Brain Res 20: 345–352PubMedCrossRefGoogle Scholar
  98. Williams GT (1991) Programmed cell death: apoptosis and oncogenesis. Cell 65: 1097–1098PubMedCrossRefGoogle Scholar
  99. Williams GT, Smith CA (1993) Molecular regulation of apoptosis: genetic controls on cell death. Cell 74: 777–779PubMedCrossRefGoogle Scholar
  100. Williams GT, Smith CA, McCarthy NJ, Grimes EA (1992) Apoptosis: final control point in cell biology. Trends Cell Biol 2: 263–267PubMedCrossRefGoogle Scholar
  101. Witte DP, Aronow BJ, Staudermann ML, Stuart WD, Clay MA, Gruppo R, Jenkins SH, Harmony JAK (1993) Platelet activation releases megakaryocyte-synthesized apolipoprotein J, a highly abundant protein in atheromatous lesions. Am J Pathol 143: 763–773PubMedGoogle Scholar
  102. Wong P, Pineault JM, Lakins J, Taillefer D, Leger JG, Wang C, Tenniswood MP (1993) Genomic organisation and expression of the rat TRPM-2 (clusterin) gene, a gene implicated in apoptosis. J Biol Chem 268: 5021–5031PubMedGoogle Scholar
  103. Wyllie AH (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555–556PubMedCrossRefGoogle Scholar
  104. Wyllie AH (1985) The biology of cell death in tumors. Anticancer Res 5: 131–136PubMedGoogle Scholar
  105. Yasuhara O, Aimi Y, McGeer E, McGeer P (1994) Expression of the complement membrane attack complex and its inhibitors in pig-disease brain. Brain Res 652: 346–349PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • C. Koch-Brandt
    • 1
  • C. Morgans
    • 2
  1. 1.Institut für BiochemieJohannes Gutenberg-UniversitätMainzGermany
  2. 2.Max Planck Institut für HirnforschungAbteilung NeurochemieFrankfurt/MainGermany

Personalised recommendations